Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Study Director
CONTACT
Lead
NKGen Biotech, Inc.
Open-label extension study to assess long-term safety and tolerability of SNK01 administered as an intravenous (IV) infusion every 3 weeks in participants with Alzheimer's Disease
Age
40–85
Sex
ALL
Healthy volunteers
Not accepted